Showing 261-270 of 354 grants

Title Institution Researcher Program Duration Total Award Amount
Exploring Immunologic Mechanisms of Indirect (Encapsulated) Islet Graft Rejection Johns Hopkins University Joshua Doloff Cures 01-November-2025 to 31-October-2028 $1,125,000.00
A Novel Bifunctional Biologic for Type 1 Diabetes Johns Hopkins University Giorgio Raimondi Cures 01-February-2025 to 31-January-2028 $995,376.00
JDRF T1D Coordinating Center Jaeb Center for Health Research Judy Sibayan Transportfolio 01-August-2019 to 31-August-2027 $2,914,531.01
Randomized Clinical Trial Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening Jaeb Center for Health Research Adam Glassman Improving Lives 01-February-2021 to 31-August-2026 $750,000.00
Studies of Promising Functional Endpoints in Eyes of Patients with Diabetes (Protocols AR and AS ) Jaeb Center for Health Research Adam Glassman Improving Lives 01-May-2026 to 30-April-2030 $1,035,583.00
Advanced Preclinical Development of iTOL-101, a Combination Investigational Product Composed of A Biotechnology-Derived Chimeric Streptavidin and A Fas Ligand (SA-FasL) Protein Bound to Biotinylated Hydrogel-Based Microparticles (Microgel) and Mixed with Deceased Donor Human Pancreatic Islets for the Treatment of Poorly-Controlled (or “Brittle”) Type 1 Diabetes iTolerance, Inc. Camillo Ricordi Cures 01-June-2022 to 31-March-2027 $850,000.00
Adult T1D Detection at Geisinger IQVIA, Inc. Nadejda Leavitt Cures 01-July-2023 to 30-June-2027 $1,033,123.00
Advancing T1D Detection and Care Through AI IQVIA, Inc. Nadejda Leavitt Cures 01-February-2025 to 31-October-2026 $345,083.00
Clinical Translation of T-1123, an Ultra-rapid, Concentrated, Temperature stable Novel Insulin Analog Invictus Therapeutics, LLC Robyn Day Improving Lives 15-October-2025 to 31-May-2027 $1,437,112.00
A multiorgan autoimmune T-cell killing in-vitro platform to improve T1D drug screening Indiana Biosciences Research Institute Roberto Mallone Cures 01-June-2026 to 31-May-2027 $196,040.47